Nektar Therapeutics (NKTR) Tax Rate Growth (5y) (2015 - 2026)
Nektar Therapeutics (NKTR) Tax Rate Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,042.03 Bn | 67,041.74 Bn | - |
| 2 | Nanobiotix | 1,908.00 Bn | 1,907.94 Bn | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - |
| 4 | BeOne Medicines | 472.89 Bn | 468.10 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.12 Bn | 114.87 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.04 Bn | 61.29 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.68 Bn | 62.68 Bn | - |
| 8 | Argenx Se | 55.90 Bn | 50.72 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.47 Bn | 34.46 Bn | 959.66 Mn |
| 10 | Nektar Therapeutics | 1.75 Bn | 1.18 Bn | 3.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7.00 |
| Dec 31, 2025 | 9,900.00 |
| Sep 30, 2025 | 11.00 |
| Jun 30, 2025 | 66.00 |
| Mar 31, 2025 | 3.00 |
| Dec 31, 2024 | -35,754.00 |
| Sep 30, 2024 | 8.00 |
| Jun 30, 2024 | 0.00 |
| Mar 31, 2024 | 21.00 |
| Dec 31, 2023 | -177.00 |
| Sep 30, 2023 | -79.00 |
| Jun 30, 2023 | -31.00 |
| Mar 31, 2023 | 32.00 |
| Dec 31, 2022 | 13,622.00 |
| Sep 30, 2022 | -7.00 |
| Jun 30, 2022 | 10.00 |
| Mar 31, 2022 | 7.00 |
| Dec 31, 2021 | 125.00 |
| Sep 30, 2021 | 24.00 |
| Jun 30, 2021 | -2.00 |